Medpace Holdings (MEDP) Non-Current Deferred Tax Liability (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Non-Current Deferred Tax Liability came in at $8.2 million in Q2 2026, up 307.09% on a YoY basis from $2.0 million in Q2 2025, and up 109.1% quarter-over-quarter from $3.9 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Non-Current Deferred Tax Liability (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Non-Current Deferred Tax Liability for 12 consecutive years, with $8.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Deferred Tax Liability rose 307.09% year-over-year to $8.2 million; the trailing twelve-month figure through Jun 2026 stood at $8.2 million (up 307.09% YoY), and the FY2025 full-year result was $1.4 million, down 97.82% from the prior year.
- Non-Current Deferred Tax Liability improved to $8.2 million in Q2 2026 per MEDP's latest filing, from $3.9 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $62.1 million in Q4 2024 and bottomed at $911000.0 in Q3 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $11.0 million across 5 years, with a median of $2.0 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Non-Current Deferred Tax Liability sank 97.82% in 2025, then surged 307.09% in 2026.
- Over 5 years, Non-Current Deferred Tax Liability stood at $47.1 million in 2022, then rose by 17.64% to $55.4 million in 2023, then increased by 12.04% to $62.1 million in 2024, then tumbled by 97.82% to $1.4 million in 2025, then soared by 505.68% to $8.2 million in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $8.2 million, $3.9 million, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.21 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 62.12 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 55.45 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 47.13 Mn |
| Sep 30, 2022 | 911,000.00 |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 35.87 Mn |
| Sep 30, 2021 | 17.60 Mn |